title: Alexithymia and somatization in general population.
abstract: OBJECTIVE
  Even though the association between alexithymia and somatization seems plausible according to several studies with selected populations, it has not been verified in carefully controlled and nationally representative population studies. We conducted such a study to find out whether alexithymia is associated with somatization at population level.
  
  
  METHODS
  This study was a part of the Finnish Health 2000 Study. The nationally representative sample comprised 5129 subjects aged 30 to 97 years. Alexithymia was measured with the 20-item Toronto Alexithymia Scale (TAS-20) and somatic symptom reporting with the 12-item somatization scale derived from the Hopkins Symptom Checklist. Sociodemographic and health-related variables, including depressive and anxiety disorders, and physician verified somatic diagnoses, were treated as confounders in multivariate analyses.
  
  
  RESULTS
  Alexithymia was associated with somatization independently of somatic diseases, depression and anxiety and confounding sociodemographic variables. The TAS-20 factor scale "Difficulties Identifying Feelings" was the strongest common denominator between alexithymia and somatization.
  
  
  CONCLUSIONS
  This was the first time the independent association between alexithymia and somatization was established in a large, nationally representative nonclinical sample of both young and old adults with and without mental disorders and somatic diseases.
authors.affiliation: Tampere School of Public Health, FIN-33014 University of Tampere, Tampere, Finland. aino.mattila@uta.fi
authors.forename: Aino K
authors.initials: AK
authors.lastname: Mattila
authors.forename: Erkki
authors.initials: E
authors.lastname: Kronholm
authors.forename: Antti
authors.initials: A
authors.lastname: Jula
authors.forename: Jouko K
authors.initials: JK
authors.lastname: Salminen
authors.forename: Anna-Maija
authors.initials: AM
authors.lastname: Koivisto
authors.forename: Riitta-Liisa
authors.initials: RL
authors.lastname: Mielonen
authors.forename: Matti
authors.initials: M
authors.lastname: Joukamaa
mesh_terms: D000328:Adult; D000342:Affective Symptoms / Q000175:diagnosis / Q000453:epidemiology* / Q000523:psychology; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D001008:Anxiety Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology; D015897:Comorbidity; D003430:Cross-Sectional Studies; D003866:Depressive Disorder / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology; D005260:Female; D005387:Finland / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D018571:Sentinel Surveillance; D012959:Socioeconomic Factors; D013001:Somatoform Disorders / Q000175:diagnosis / Q000453:epidemiology* / Q000523:psychology; D011795:Surveys and Questionnaires